Navigating AI’s rapid change together: A health plan partnership approach

April 15, 2026

EGWP marketplace medicaid Medicare

Artificial intelligence (AI) is rapidly transforming how we interact with the world around us – whether through our phones, at the doctor’s office or even the workplace – it is a technology poised to reshape industries in unimaginable ways. Within our industry, however, the future of AI is nuanced with additional factors – shifting member and provider needs, advances in healthcare and navigating the ever-changing complex regulatory environment.

For health plans, constant evolution and adaptation will be key for success as AI continues to transform healthcare and the member experience. At Evernorth, change means understanding direction and technological advancements in healthcare techniques and medicine. We must also adapt and adjust to legislative and policy changes, including changes in administration at the state, federal and even international levels.

Thoughtful, flexible innovation coupled with responsibility will transform the comprehensive care that Evernorth offers, while keeping the service of clients and members as our North Star.

So, what can Evernorth clients do? What’s the best way we can make the most of our partnership?

As Evernorth continues to evaluate and responsibly evolve, we will continue to keep you updated on AI. In the meantime, we encourage plans to do the following:

  • Continually evaluate your RFP language and sales communication on this topic.
  • Attend upcoming Evernorth client forums to learn more. (Medicaid and Marketplace Client Forum – May 21)
  • Reach out to your Evernorth account team with any questions.

We look forward to continuing our partnership with you as we navigate these changes together and identify responsible ways to improve outcomes for your members.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

survey results

Take the 1-Minute survey

Thank you for being a valued reader of Regulated Times. Take our brief, anonymous survey in less than one minute and help shape the future of Regulated Times.

As we continue to evolve the newsletter, we’d love to hear your thoughts. Your feedback will help us better understand what content is most valuable, whether the current publication frequency is meeting your needs, and how we can improve your overall experience.
read more >

June 19, 2026

EGWP marketplace medicaid Medicare

Initiatives

PCMA launches new affordability campaign

PCMA rolled out a new seven-figure multi-channel advertising campaign focused on affordability. The campaign, which has been covered by Bloomberg, Inside Health Policy, and Politico, will include digital, email, and streaming advertising, events, podcasts, a new microsite, and a suite of resources designed to better explain how PBMs work and the outsized value they deliver […]
read more >

June 10, 2026

EGWP marketplace medicaid Medicare